Hydrogen is used directly or indirectly as natural resource within pharmaceutical-chemical industry. Today, only grey hydrogen from fossil energy carriers, which is not sustainable, is used for the greater part.

Additionally, the transport of hydrogen over long distances is unprofitable and cost-intensive. Contaminated sewage sludge with up to 30 % of plastic content from production processes has to be disposed expensively and in a complex way. The energetic potential is not exploited.

The current situation requires innovative solutions and new supply models.

Why not producing the required hydrogen on-site and in addition sustainably?

Our blueFLUX H2 plant produces sustainably produced green hydrogen, syngas, peat substitutes, synthetic coal, vegetable charcoal, bio-methane & bio-methanol.

The utilization of hydrogen has to emerge where reduction of emissions occur and where they are most praiseworthy from an economic point of view. This means close to consumers. Pharmaceutical-chemical industry unites the supply of organic residues and sewage sludge as well as the requirement of sustainable obtained hydrogen.

A perfect opportunity for further sustainability in production.

The pharmaceutical-chemical industry is a large consumer of H2 and at the same time has the opportunity to become a producer of sustainably produced green H2 for its own needs by using blueFLUX H2, thereby improving the complex disposal and optimising costs.

These new raw materials/energy carriers can be directly consumed by the pharmaceutic-chemical industry for the own demand.

Our customers become self-provider for green energy carriers or they can sell redundant green energy through the usage of the blueFLUX technology.